A pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111)
Keyword(s):
Keyword(s):
2017 ◽
Vol 17
(2)
◽
pp. 133-146
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 108
(3)
◽
pp. e77-e78
Keyword(s):
Keyword(s):
2013 ◽
Vol 13
(1)
◽
Keyword(s):
Keyword(s):